BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Deals

Boston Biomedical, Dainippon Sumitomo deal

Dainippon received an option to license exclusive rights to develop and commercialize Boston Biomedical's BBI608 for cancer in Japan. Dainippon also received an exclusive right of negotiation for...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >